These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38365136)

  • 1. The usefulness of the retina for identifying people with type 2 diabetes with prodromal stages of dementia.
    Ciudin A; Hernández C; Simó-Servat O; Simó R
    Neurosci Biobehav Rev; 2024 Apr; 159():105592. PubMed ID: 38365136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes.
    Ciudin A; Simó R
    Front Endocrinol (Lausanne); 2022; 13():1024794. PubMed ID: 36531450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus.
    Groeneveld O; Reijmer Y; Heinen R; Kuijf H; Koekkoek P; Janssen J; Rutten G; Kappelle L; Biessels G;
    Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1253-1260. PubMed ID: 30355471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Metabolic Retinal Changes Associated With Mild Cognitive Impairment in Type 2 Diabetes.
    Pedersen FN; Stokholm L; Lois N; Yang D; Cheung CY; Biessels GJ; Exalto L; Simó R; Peto T; Pouwer F; Grauslund J
    Diabetes; 2023 Dec; 72(12):1853-1863. PubMed ID: 37725903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal Microperimetry: A New Tool for Identifying Patients With Type 2 Diabetes at Risk for Developing Alzheimer Disease.
    Ciudin A; Simó-Servat O; Hernández C; Arcos G; Diego S; Sanabria Á; Sotolongo Ó; Hernández I; Boada M; Simó R
    Diabetes; 2017 Dec; 66(12):3098-3104. PubMed ID: 28951388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Eye Fixation Assessment for Identifying Type 2 Diabetic Subjects at Risk of Dementia.
    Simó-Servat O; Ciudin A; Ortiz-Zúñiga ÁM; Hernández C; Simó R
    J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30626106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gaze Fixation Assessed by Microperimetry: A Useful Tool for the Monitoring of the Cognitive Function in Patients with Type 2 Diabetes.
    Ortiz-Zúñiga ÁM; Simó-Servat O; Rojano-Toimil A; Vázquez-de Sebastian J; Castellano-Tejedor C; Hernández C; Simó R; Ciudin A
    J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance Imaging in Stable Mild Cognitive Impairment, Prodromal Alzheimer's Disease, and Prodromal Dementia with Lewy Bodies.
    Siddiqui TG; Whitfield T; Praharaju SJ; Sadiq D; Kazmi H; Ben-Joseph A; Walker Z
    Dement Geriatr Cogn Disord; 2020; 49(6):583-588. PubMed ID: 33227783
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Majimbi M; McLenachan S; Nesbit M; Chen FK; Lam V; Mamo J; Takechi R
    Front Endocrinol (Lausanne); 2023; 14():1224418. PubMed ID: 37850093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
    Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal sensitivity and gaze fixation evaluated by microperimetry in subjects with type 2 diabetes: two independent parameters that explore different neuronal circuits.
    Ortiz-Zuñiga AM; Rojano Toimil A; Rahnama K; Lainez E; Raguer N; Simó-Servat O; Hernández C; Simó R; Ciudin A
    J Endocrinol Invest; 2023 Sep; 46(9):1875-1880. PubMed ID: 36870015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of diagnostic constructs for cognitive impairment in patients with type 2 diabetes mellitus.
    Groeneveld ON; van den Berg E; Rutten GEHM; Koekkoek PS; Kappelle LJ; Biessels GJ;
    Diabetes Res Clin Pract; 2018 Aug; 142():92-99. PubMed ID: 29802950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes-specific dementia risk score (DSDRS) predicts cognitive performance in patients with type 2 diabetes at high cardio-renal risk.
    Verhagen C; Janssen J; Exalto LG; van den Berg E; Johansen OE; Biessels GJ
    J Diabetes Complications; 2020 Oct; 34(10):107674. PubMed ID: 32723590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease: A Longitudinal Cohort Study.
    Becker S; Bode M; Brockmann K; Gasser T; Michaelis K; Solbrig S; Nuerk HC; Schulte C; Maetzler W; Zimmermann M; Berg D; Liepelt-Scarfone I
    Neurology; 2022 Dec; 99(23):e2548-e2560. PubMed ID: 36240089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes is an independent risk factor for dementia conversion in patients with mild cognitive impairment.
    Ciudin A; Espinosa A; Simó-Servat O; Ruiz A; Alegret M; Hernández C; Boada M; Simó R
    J Diabetes Complications; 2017 Aug; 31(8):1272-1274. PubMed ID: 28545893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids.
    Brook E; Mamo J; Wong R; Al-Salami H; Falasca M; Lam V; Takechi R
    Pharmacol Res; 2019 Mar; 141():291-297. PubMed ID: 30616019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on cognitive decline and dementia in elderly patients with diabetes.
    Bordier L; Doucet J; Boudet J; Bauduceau B
    Diabetes Metab; 2014 Nov; 40(5):331-7. PubMed ID: 24703603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline.
    Ben Assayag E; Eldor R; Korczyn AD; Kliper E; Shenhar-Tsarfaty S; Tene O; Molad J; Shapira I; Berliner S; Volfson V; Shopin L; Strauss Y; Hallevi H; Bornstein NM; Auriel E
    Stroke; 2017 Sep; 48(9):2368-2374. PubMed ID: 28801477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
    Gasca-Salas C; García-Lorenzo D; Garcia-Garcia D; Clavero P; Obeso JA; Lehericy S; Rodríguez-Oroz MC
    Brain Imaging Behav; 2019 Feb; 13(1):180-188. PubMed ID: 28710667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of retinal and hippocampal thickness in patients with amnestic mild cognitive impairment and healthy controls.
    Donix M; Wittig D; Hermann W; Haussmann R; Dittmer M; Bienert F; Buthut M; Jacobi L; Werner A; Linn J; Ziemssen T; Brandt MD
    Brain Behav; 2021 May; 11(5):e02035. PubMed ID: 33448670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.